1972
DOI: 10.1007/bf00422614
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia-induced amnesia in one-trial learning and pharmacological protection by piracetam

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0

Year Published

1979
1979
2015
2015

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(16 citation statements)
references
References 9 publications
0
16
0
Order By: Relevance
“…Anti-amnesic activity was assayed in scopolamine-in duced amnesia rats by the step-through one-trial passive avoidance method with a two-compartment apparatus (12). The apparatus consisted of a large white compart ment (30 X 30 X 30 cm) and a small black compart ment (10 X 10 X 10 cm) which were connected with a guillotine door (6 X 6 cm).…”
mentioning
confidence: 99%
“…Anti-amnesic activity was assayed in scopolamine-in duced amnesia rats by the step-through one-trial passive avoidance method with a two-compartment apparatus (12). The apparatus consisted of a large white compart ment (30 X 30 X 30 cm) and a small black compart ment (10 X 10 X 10 cm) which were connected with a guillotine door (6 X 6 cm).…”
mentioning
confidence: 99%
“…(Ostrowski, Keil, & Schraven, 1975). However, many studies have reported piracetam facilitation 30 min following injection (Giurgea et aI., 1971 ;Sara & David-Rernacle, 1974 ;Sara & Lefevre, 1972;Wolthuis , 1971).…”
Section: Discussionmentioning
confidence: 99%
“…In rats, piracetam has been found to facilitate acquisition of a lightsignaled active avoidance in a Y maze (Wolthuis, 1971) and to reduce errors and escape latency in a four-choice water-filled maze (Giurgea & Mouravieff-Lesiusse, 1972). It has also been shown to protect against the amnestic effects of electroconvulsive shock (Sara & David-Remacle, 1974) and hypoxia (Giurgea, Lefevre, & Lescrenier, 1971;Sara & Lefevre, 1972 …”
mentioning
confidence: 99%
“…Piracetam has also been observed to increase the blood flow in some situations, probably because of decreased platelet aggregation, enhancement of red blood cell deformability and reduction in adherence of damaged erythrocytes to endothelial cells 23 . It is proposed that the beneficial effect of nootropics may be the result of improvement in cerebral circulation and brain metabolism 24 . Results like these have often led to the classification of the piracetam-1ike nootropics as cerebral metabolic enhancers.…”
Section: Observations and Resultsmentioning
confidence: 99%